Comparative Pharmacology
Head-to-head clinical analysis: EDECRIN versus FUROSEMIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: EDECRIN versus FUROSEMIDE.
EDECRIN vs FUROSEMIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ethacrynic acid inhibits the Na-K-Cl cotransporter (NKCC2) in the thick ascending limb of the loop of Henle, reducing reabsorption of sodium, chloride, and potassium, leading to diuresis.
Furosemide is a loop diuretic that inhibits the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, reducing reabsorption of sodium, chloride, and potassium ions, leading to increased urine output.
Oral: 50-100 mg once or twice daily, maximum 400 mg/day. IV: 50 mg (0.5 mg/kg) once, may repeat once at 2-hour intervals if needed.
Adults: 20-80 mg orally once or twice daily; IV/IM: 20-40 mg once or twice daily, may increase by 20-40 mg every 6-8 hours. Max dose: 600 mg/day.
None Documented
None Documented
Clinical Note
moderateFurosemide + Digoxin
"The risk or severity of adverse effects can be increased when Furosemide is combined with Digoxin."
Clinical Note
moderateFurosemide + Digitoxin
"The risk or severity of adverse effects can be increased when Furosemide is combined with Digitoxin."
Clinical Note
moderateFurosemide + Deslanoside
"The risk or severity of adverse effects can be increased when Furosemide is combined with Deslanoside."
Clinical Note
moderateFurosemide + Acetyldigitoxin
Terminal elimination half-life is 2-4 hours; prolonged in renal impairment (up to 30 hours) and in heart failure.
0.5-2 hours (terminal); prolonged in renal impairment (up to 9-24 hours) and hepatic cirrhosis (up to 2-4 hours).
Approximately 60-70% excreted unchanged in urine via glomerular filtration and tubular secretion; remaining 30-40% eliminated via biliary/fecal route.
Renal (50-80% unchanged; remainder as glucuronide metabolite); fecal (<2%).
Category C
Category A/B
Loop Diuretic
Loop Diuretic
"The risk or severity of adverse effects can be increased when Furosemide is combined with Acetyldigitoxin."